研究業績(原著と症例報告のみ) 2013年

原著
1.
A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS). Ihara T, Furusyo N, Hayashi T, Toyoda K, Murata M, Hayashi J. Arch Virol 158: 2465-72, 2013.
2.
Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study. Ogawa E, Furusyo N, Kajiwara E, Takahashi K, Nomura H, Maruyama T, Tanabe Y, Satoh T, Nakamuta M, Kotoh K, Azuma K, Dohmen K, Shimoda S, Hayashi J; The Kyushu University Liver Disease Study (KULDS) Group. J Hepatol 58: 495-501, 2013.
3.
Early phase viral kinetics of chronic hepatitis C patients receiving telaprevir-based triple therapy: a comparison of two real-time PCR assays. Ogawa E, Furusyo N, Murata M, Toyoda K, Eiraku K, Shimizu M, Harada Y, Mitsumoto F, Takayama K, Okada K, Kainuma M, Hayashi J. Antiviral Res 99: 119-124, 2013.
4.
Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy. Ogawa E, Furusyo N, Nakamuta M, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Satoh T, Azuma K, Kawano A, Tanabe Y, Kotoh K, Shimoda S, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group. J Hepatol 59: 667-674, 2013.
5.
Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study. Ogawa E, Furusyo N, Nakamuta M, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Satoh T, Azuma K, Kawano A, Tanabe Y, Kotoh K, Shimoda S, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group. Aliment Pharmacol Ther 38: 1076-1085, 2013.
6.
Valuable antiviral therapeutic options for the treatment of chronic hepatitis C patients with thrombocytopenia. Ogawa E, Furusyo N, Murata M, Ikezaki H, Ihara T, Hayashi T, Toyoda K, Okada K, Kainuma M, Kajiwara E, Takahashi K, Satoh T, Hayashi J. J Viral Hepat 20: 838-846, 2013.
7.
Plasma glycated albumin level and atherosclerosis: Results from the Kyushu and Okinawa Population Study (KOPS). Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J. Int J Cardiol 167: 2066-2072, 2013.
8.
The serum undercarboxylated osteocalcin level in the Japanese population: Results from the Kyushu and Okinawa Population Study (KOPS). Furusyo N, Ihara T, Hayashi T, Ikezaki H, Toyoda K, Ogawa E, Okada K, Kainuma M, Murata M, Hayashi J. Endocrine 43: 635-642, 2013.
9.
Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women. Furusyo N, Ai M, Okazaki M, Ikezaki H, Ihara T, Hayashi T, Hiramine S, Ura K, Kohzuma T, Schaefer EJ, Hayashi J. Atherosclerosis 231: 238-245, 2013.
10.
Association between chronic hepatitis C virus infection and high levels of circulating N-terminal pro-brain natriuretic peptide. Okada K, Furusyo N, Ogawa E, Ikezaki H, Ihara T, Hayashi T, Kainuma M, Murata M, Hayashi J. Endocrine 43: 200-205, 2013.
11.
Commentary: Triple therapy for patients with chronic hepatitis C and advanced fibrosis? Authors' reply. Ogawa E, Furusyo N, Hayashi J. Aliment Pharmacol Ther 38: 1408, 2013.
12.
Reply to: "Lower incidence of hepatocellular carcinoma in patients with transient virologic response to peginterferon and ribavirin combination therapy: is it really the effect of the therapy?" Ogawa E, Furusyo N, Hayashi J. J Hepatol 58: 839-840, 2013.
13.
Pretreatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients. Ahmed WH, Furusyo N, Zaky S, Eldin AS, Aboalam H, Ogawa E, Murata M, Hayashi J. World J Gastroenterol 19: 1387-1395, 2013.
14.
Impact of Conversion From Pegylated interferon-α2b to interferon-α2a for treating recurrent hepatitis C after liver transplantation. Ikegami T, Shirabe K, Yoshizumi T, Furusyo N, Kotoh K, Kato M, Shimoda S, Soejima Y, Motomura T, Fukuhara T, Maehara Y. Transplantation 95: e38-42, 2013.
15.
Early extensive viremia, but not rs8099917 genotype, is the only predictor for cholestatic hepatitis C after living-donor liver transplantation. Ikegami T, Shirabe K, Fukuhara T, Furusyo N, Kotoh K, Kato M, Shimoda S, Aishima S, Soejima Y, Yoshizumi T, Maehara Y. Hepatol Res 43: 621-629, 2013.


症例報告
1.
A case report of human immunodeficiency virus-associated anaplastic lymphoma kinase protein-negative anaplastic large cell lymphoma. Taniai H, Furusyo N, Murata M, Mitsumoto F, Shimizu M, Toyoda K, Ogawa E, Kainuma M, Okada K, Hayashi J. Springerplus 2: 400, 2013.
2.
長期のアデホビル投与によりFanconi 症候群を来したB 型慢性肝炎の1 例 熊手絵璃、古庄憲浩、光本富士子、小川栄一、豊田一弘、貝沼茂三郎、村田昌之、林 純 肝臓 54: 187-193, 2013.
3.
低K血症を契機に前立腺癌由来の異所性ACTH症候群が疑われた一例 武田倫子、大西八郎、澤山泰典 日本病院総合診療医学会雑誌 4(2): 41-44, 2013.
4.
膵癌が疑われた限局性自己免疫性膵炎の1例 加藤禎史、古庄憲浩、小川栄一、光本富士子、谷合啓明、豊田一弘、永楽訓三、林 純 日本病院総合診療医学会雑誌 4(1): 46-49, 2013.
5.
気胸を呈したAIDS合併ニューモシスチス肺炎の一例 加藤禎史、古庄憲浩、村田昌之、小川栄一、光本富士子、熊手絵璃、谷合啓明、豊田一弘、林 純 日本病院総合診療医学会雑誌 4(2): 45-49, 2013.
6.
高齢男性に発症した全身性エリテマトーデスの1例 畑島 梓、古庄憲浩、光本富士子、小川栄一、豊田一弘、谷合啓明、貝沼茂三郎、岡田享子、 村田昌之、林 純 日本病院総合診療医学会雑誌 4(2): 50-54, 2013.
7.
頸部リンパ節切除後に改善したCastleman病の一例 山嵜 奨、古庄憲浩、小川栄一、酒見倫子、熊手絵璃、豊田一弘、谷合啓明、岡田享子、貝沼茂三郎、村田昌之、林 純 日本病院総合診療医学会雑誌 4(2): 55-59, 2013.
8.
不明熱と全身リンパ節腫大が発見の契機となった加齢性Epstein-Barr Virus関連リンパ増殖異常症の一例 加藤禎史、古庄憲浩、光本富士子、村田昌之、小川栄一、豊田一弘、新野大介、大島孝一、林 純 日本病院総合診療医学会雑誌 5(1): 10-14, 2013.
9.
急性心筋梗塞を契機に発見された緩徐進行1型糖尿病(SPIDDM)の一例 高山耕治、古庄憲浩、岡田享子、大西八郎、豊田一弘、小川栄一、貝沼茂三郎、村田昌之、林 純 日本病院総合診療医学会雑誌 5(1): 15-18, 2013.
10.
発熱と歩行障害を契機に診断された孤発性Creutzfeldt-Jakob病の一例 酒見倫子、大西八郎、澤山泰典 日本病院総合診療医学会雑誌 5(1): 19-22, 2013.
11.
腰椎に発生した骨原発悪性リンパ腫の一例 田中祐樹、古庄憲浩、永樂訓三、豊田一弘、小川栄一、村田昌之、林 純 日本病院総合診療医学会雑誌 5(2): 56-61, 2013.

研究分野・研究実績トップへ戻る